Bigul

Supriya Lifescience Ltd - 543434 - Board Meeting Outcome for Outcome Of Board Meeting In Accordance With SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Pursuant to Regulation 33 read with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please be informed that the Board of Directors of the Company at its Meeting held on Wednesday, February 7, 2024, inter-alia has: 1. Considered and approved the Unaudited Financial Results for the quarter and nine months ended December 31, 2023. 2. Approved the Capital Expenditure plan at Ambernath site for CDMO facility
07-02-2024
Bigul

Supriya Lifescience Ltd - 543434 - Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2023

Supriya Lifescience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2024 ,inter alia, to consider and approve the Unaudited Financial Results for the quarter and nine months ended December 31, 2023.
30-01-2024
Bigul

Supriya Lifescience Ltd - 543434 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Please find attached herewith certificate under Reg 74(5) of SEBI DP Regulation, 2018.
08-01-2024
Next Page
Close

Let's Open Free Demat Account